26 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
or supplier.
Any of these events could lead to clinical trial delays or failure to obtain regulatory approval, or impact VBL’s ability to successfully … for the manufacturing of its product candidate. Each supplier may require licenses to manufacture components of VBL’s product candidate or to utilize
S-4/A
z9izn5l bg
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
hhhxbcaplnbh9xxi
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
kgyto idgbp
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-1.1
bqut2x4a 5joffa1
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
20-F
il1ni q1o5j
25 Mar 15
Annual report (foreign)
12:00am